沛爾生技醫藥股份有限公司 News Releases

PURE BioMedicine Q4 2025 Financial Report

PURE BioMedicine Co., Ltd. reported an operating revenue of 31 million NTD and a net loss of 453 mil… · 2025-12-01

[P.E. Biopharm Corporation] 2026 Q1 EPS -1.18 NTD

P.E. Biopharm Corporation reported a basic earnings per share (EPS) of -1.18 NTD for Q1 2026. The co… · 2026-03-01

PURE BioMedicine Q4 2025 Financial Report

PURE BioMedicine Co., Ltd. reported an operating revenue of 31 million NTD and a net loss of 453 mil… · 2025-12-01

[P.E. Biopharm Corporation] 2026 Q1 EPS -1.18 NTD

P.E. Biopharm Corporation reported a basic earnings per share (EPS) of -1.18 NTD for Q1 2026. The co… · 2026-03-01